MaxHealth Medicine Group

Established in 2009, the MaxHealth Medical Group works with world-class manufacturers of pharmaceutical products and medical technologies to open up the Chinese market to them. MaxHealth has an interest in medical technologies that can transform existing treatment processes and bring about significant benefits to patient and physicians. The company partners with innovative companies to commercialise medical technologies for the Chinese market through investments, joint ventures and technology licensing.

Tony Miao

CEO

1 past transactions

Zilico

Corporate Round in 2018
Zilico is developing the next generation of cancer diagnostics that will provide real-time diagnosis for cervical cancer and reduce the inherent subjectivity of current methods. Two applications are under development: the first for the referral market and the second for the screening market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.